NCT02244307View on ClinicalTrials.gov

Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade

CompletedOBSERVATIONAL
Enrollment

4,561

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

June 30, 2003

Conditions
Prostatic Hyperplasia
Interventions
DRUG

alpha-adrenergic blocker

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02244307 - Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade | Biotech Hunter | Biotech Hunter